European Journal of Business and Management ISSN 2222-1905 (Paper) ISSN 2222-2839 (Online) www.iiste.org Financial Analysis of Selected Pharmaceutical Companies in Bangladesh Md. Tofael Hossain Majumder (Corresponding Author) Lecturer‚ Department of Accounting and Information Systems Comilla University‚ Comilla‚ Bangladesh. Phone: +8801816436176‚ Email: tofael_cou@yahoo.com Mohammed Mizanur Rahman Lecturer‚ School of Business and Economics Atish Dipankar University of Science and Technology
Premium Financial ratios Financial ratio Generally Accepted Accounting Principles
1. The Xavier Company‚ a merchandising firm‚ has planned the following sales for the next four months: | | |March |April |May |June | | |Total budgeted sales |$70‚000 |$50‚000 |$80‚000 |$60‚000 | Sales are made 40% for cash and 60% on account. From experience‚ the company has learned that a month’s sales on account are collected according to the following pattern:
Premium Direct material price variance Material Wage
SUBJECT: DESIGN COMPANY NOVARTIS HELLAS pharmaceuticals firms PEST ANALYSIS To understand the impact of the environment in any industry‚ it is imperative to consider four main factors that influence this particular political‚ economic‚ social and technological factors. It is a fact that in Greece factors are rather disproportionate influence on the functioning of a healthy market competition. The business environment is regulated by opaque procedures‚ middlemen‚ bureaucrats‚ businessmen and
Premium Pharmacology Pharmaceutical industry Pharmacy
paper is to analyze federal antitrust enforcers are investigating whether a multinational pharmaceutical company has attempted to minimize the impact of generic competition to one of its most profitable prescription drugs. This anti-depressant drug is the company’s best seller‚ with sales last year of $2.11 billion‚ representing a 22% increase from the year before. I will review whether pharmaceutical companies have engaged in activities that will prevent generic brands to the prescription drug from
Premium Pharmacology Generic drug Food and Drug Administration
Entrepreneurship Case study QI-TECH: A Chinese Technology Company for Sale Name: Choi Ying Kai SID: 06523393 Date edited: 11-11-2007 Case background: QI-TECH‚ a Chinese manufacturer of precision Coordinate Measurement Machines‚ is a joint venture established by Indiver BV‚ a Dutch aircraft engine manufacturer and a Chinese state-owned enterprise QQMF. Looking for a strategic exit‚ Indiver BV‚ which holds 50% of QI-TECH‚ must negotiate a sale with its Chinese partner and a potential buyer‚ Brown
Premium Negotiation Joint venture China
RESEARCH AND DEVELOPMENT SCENARIO IN INDIAN PHARMACEUTICAL COMPANIES SUBMITED BY: MR. SHAMSHAD AH DEPARTMENT OF PHARMACEUTICAL MANAGEMENT DEPARTMENT OF PHARMACEUTICAL MANAGEMENT NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH SEC. NO. 67‚ S.A.S. NAGAR MOHLI PUNJAB CONTENTS: * OBJECTIVES....................................................................................3 * INTRODUCTION.............................................................................3
Premium Pharmaceutical industry Clinical trial Drug discovery
the Christian Church‚ democracy came to be understood as representative democracy. During the 18th century‚ the notion of a representative
Premium Democracy Government Ancient Greece
Cooper Pharmaceuticals Inc BMKT 436: Sales and Sales Management Shaye Murphy 10/12/2013 Executive Summary Goals Cooper Pharmaceuticals Inc (CPI) is a major manufacturer for the dental and medical practices in the United States. Their ultimate goal is to remain the largest drug manufacturer and meet the sales quotas. CPI has strong ethical policies that they want to keep that have shaped the companies’ reputation. In hiring Bob Marsh‚ they were meeting their goals
Premium Sales Customer service Marketing
Problems Faced by Small and Medium Pharmaceutical Companies Small and medium enterprises (SMEs) in their endeavour towards trans-nationalization and exports are confronted with several issues. These include: lack of expertise‚ training and finance for technological up-gradation and adoption of good manufacturing practices (GMP) by SMEs to meet global quality standards; limited exposure and expertise on IPR issues; limited adoption of information technology (IT) techniques in production and processes;
Premium Pharmacology Pharmaceutical industry Drug
Abbreviations 1. AAIFR - Appellate Authority for Industrial and Financial Reconstruction 2. BIFR- Board for Industrial and Financial Reconstruction 3. CLB – Company Law Board 4. NCLT – National Company Law Tribunal 5. NCALT – National Company Law Appellate Tribunal 6. SICA - Sick Industrial Companies (Special Provisions) Act‚ 1985 Table of Cases 1. RDF Power Projects Ltd v. M. Muralikrishna‚ (2005) 124 Comp Cas 184 (AP) 2. Union of India v. R. Gandhi‚ President
Premium Judge Supreme Court of the United States Court